We welcome the initiative of the European Commission to review the legal frameworks for medicines for children and rare diseases to address their shortcomings. As identified, it is important to stimulate development of medicines for unmet needs and ensure equal access for patients in all EU countries.
EAR
European Alliance for Responsible R&D and Affordable Medicines
NGO · Belgium
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts — staff, costs, accreditations — are not available for it.
2
positions filed
in the 583 files tracked
2
legislative files
of 583 tracked
2
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track European in PolicySpeak: request access →
Work at European Alliance for Responsible R&D and Affordable Medicines? so we know who speaks for it.
Their record over time
European Alliance for Responsible R&D and Affordable Medicines filed 2 positions between 21 Dec 2020 and 29 Apr 2022, across 2 of the 583 legislative files tracked here, attaching a full position paper 2 times.
2020 · 1 filed2022 · 1 filed
What they argued
The European Alliance for Responsible R&D and Affordable Medicines welcomes the opportunity to provide feedback within this call for evidence in preparation of an impact assessment of compulsory licensing in the EU.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put European Alliance for Responsible R&D and Affordable Medicines next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Showing 5 of 17.
Is this your organization?
Everything on this page comes from European Alliance for Responsible R&D and Affordable Medicines’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.